Your browser doesn't support javascript.
loading
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/guidance on the use of clinically assisted hydration in patients with advanced cancer.
Hayes, Jo; Bruera, Eduardo; Crawford, Gregory; Fleury, Mapi; Santos, Marcos; Thompson, Jo; Davies, Andrew.
Afiliação
  • Hayes J; St. Catherine's Hospice, Crawley, UK.
  • Bruera E; The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Crawford G; University of Adelaide and Northern Adelaide Local Health Network, Adelaide, Australia.
  • Fleury M; Department of Oncology, CHUV, Lausanne University Hospital, Lausanne, Switzerland.
  • Santos M; CONFIAR Radiotherapy, Goiania, Brazil.
  • Thompson J; Royal Surrey County Hospital, Guildford, UK.
  • Davies A; Trinity College Dublin, University College Dublin, Our Lady's Hospice, Dublin, Ireland. andavies@tcd.ie.
Support Care Cancer ; 32(4): 228, 2024 Mar 13.
Article em En | MEDLINE | ID: mdl-38478135
ABSTRACT

PURPOSE:

The provision of clinically assisted hydration (CAH) in patients with advanced cancer is controversial, and there is a paucity of specific guidance and so a diversity in clinical practice. Consequently, the Palliative Care Study Group of the Multinational Association of Supportive Care in Cancer (MASCC) formed a sub-group to develop evidence-based guidance on the use of CAH in patients with advanced cancer.

METHODS:

This guidance was developed in accordance with the MASCC Guidelines Policy. A search strategy for Medline was developed, and the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials were explored for relevant reviews/trials, respectively.

RESULTS:

Due to the paucity of evidence, the sub-group was not able to develop a prescribed guideline, but was able to generate a number of "expert opinion statements" these statements relate to assessment of patients, indications for CAH, contraindications for CAH, procedures for initiating CAH, and reassessment of patients.

CONCLUSIONS:

This guidance provides a framework for the use of CAH in advanced cancer, although every patient requires individualised management.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Hidratação / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Hidratação / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article